Results 121 to 130 of about 1,349 (221)
Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo +7 more
wiley +1 more source
Evaluating post 2024 election scenarios for the UK based on political party manifestos. [PDF]
Stafford R +16 more
europepmc +1 more source
Abstract The integrity of scholarly communication depends critically on the accuracy and verifiability of cited references. Citations enable readers to trace prior work, assess evidence, and situate new contributions within the existing literature. However, concerns have emerged regarding the presence of references in published papers that cannot be ...
Chengcheng Han +3 more
wiley +1 more source
What is the relationship between population health and voting patterns: an ecological study in England. [PDF]
Laverty AA, Hopkinson NS.
europepmc +1 more source
Abstract This paper describes an arthroscopic technique for managing anterior cruciate ligament (ACL) tibial avulsion fractures. The procedure combines a 3‐tunnel anchoring construct with cortical button fixation in a crossed‐loop configuration. The method aims to enhance 3‐dimensional stability and provides improved fixation strength compared with ...
Changchao Wang +7 more
wiley +1 more source
The Role of Threats in the Support of System-Justifying Beliefs. [PDF]
Prusova IS, Gorokhova AS.
europepmc +1 more source
Abstract Aim Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, acquired haematopoietic stem cell disorder. Crovalimab, a complement C5‐inhibitor, is approved for PNH and can be self‐administered subcutaneously every 4 weeks, offering a more convenient route than intravenous C5‐inhibitors.
Mendy ter Avest +4 more
wiley +1 more source
Environmental conservation and food production
openaire +3 more sources
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon +7 more
wiley +1 more source

